InnovaRx Innova Health Strategies

Search Index Browse Meds Risk score

Pricing Sign in

Code set

/

Medications ›mirvetuximab soravtansine-gynx

mirvetuximab soravtansine-gynx

RxCUI 2621549 precise ingredient

Indicated for · 28

Abdominal Neoplasms Adnexal Diseases Carcinoma Carcinoma, Ovarian Epithelial Digestive System Diseases Digestive System Neoplasms Disease Diseases, Life Phases, Behavior Mechanisms and Physiologic States Endocrine Gland Neoplasms Endocrine System Diseases Fallopian Tube Diseases Fallopian Tube Neoplasms Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Genital Diseases Genital Diseases, Female Genital Neoplasms, Female Gonadal Disorders Neoplasms Neoplasms by Histologic Type Neoplasms by Site Neoplasms, Glandular and Epithelial Ovarian Diseases Ovarian Neoplasms Peritoneal Diseases Peritoneal Neoplasms Urogenital Diseases Urogenital Neoplasms

MED-RT, published by the VA through NLM. Relationships attach at the ingredient level, not to a specific product or dose.

InnovaRx — Innova Health Strategies. ICD-10-CM and the CMS-HCC risk adjustment models are published by CMS and NCHS and are in the public domain. Effective date 2026-08-30 travels in the URL, so this link shows anyone exactly what you see.

Age Sex for age/sex edits only

No codes yet. Add them from a code page or the index walker.